Vimarsana
Biggest News Aggregation in the World

Page 5 - Eric Zi News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Eric Zi. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Eric Zi Today - Breaking & Trending Today

Venus Medtech Concludes Acquisition of 100% Equity Interest in Cardiovalve - Vimarsana News

Venus Medtech Concludes Acquisition of 100% Equity Interest in Cardiovalve

HANGZHOU, China, Jan. 25, 2022 /PRNewswire/ -- Venus Medtech (Hangzhou) Inc. (Venus MedTech, 2500.HK), a leading, innovative Chinese structural he...

Venus Medtech Concludes Acquisition of 100% Equity Interest in Cardiovalve - Vimarsana News

Venus Medtech Concludes Acquisition of 100% Equity Interest in Cardiovalve

/PRNewswire/ -- Venus Medtech (Hangzhou) Inc. (Venus MedTech, 2500.HK), a leading, innovative Chinese structural heart disease treatment company, announced its...

Venus Medtech (Hangzhou) Inc.: Venus Medtech Concludes Acquisition of 100% Equity Interest in Cardiovalve - Vimarsana News

Venus Medtech (Hangzhou) Inc.: Venus Medtech Concludes Acquisition of 100% Equity Interest in Cardiovalve

HANGZHOU, China, Jan. 26, 2022 /PRNewswire/ -- Venus Medtech (Hangzhou) Inc. (Venus MedTech, 2500.HK), a leading, innovative Chinese structural heart disease treatment company, announced its

Venus Medtech Acquires Cardiovalve to Optimize its Innovative Products Pipeline of Mitral and Tricuspid Valve Replacement - Vimarsana News

Venus Medtech Acquires Cardiovalve to Optimize its Innovative Products Pipeline of Mitral and Tricuspid Valve Replacement

/CNW/ -- Venus Medtech (Hangzhou) Inc. (Venus MedTech, 2500.HK), a leading, innovative Chinese structural heart disease treatment company, announced its...

Venus Medtech Acquires Cardiovalve to Optimize its Innovative Products Pipeline of Mitral and Tricuspid Valve Replacement - Vimarsana News

Venus Medtech Acquires Cardiovalve to Optimize its Innovative Products Pipeline of Mitral and Tricuspid Valve Replacement

/PRNewswire/ -- Venus Medtech (Hangzhou) Inc. (Venus MedTech, 2500.HK), a leading, innovative Chinese structural heart disease treatment company, announced its...